SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
TNFA
Price
$0.06
Change
-$0.03 (-33.33%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
873.74K
Interact to see
Advertisement

SLXN vs TNFA

Header iconSLXN vs TNFA Comparison
Open Charts SLXN vs TNFABanner chart's image
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
TNF Pharmaceuticals
Price$0.06
Change-$0.03 (-33.33%)
Volume$471.6K
Capitalization873.74K
SLXN vs TNFA Comparison Chart in %
Loading...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLXN vs. TNFA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a StrongBuy and TNFA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (SLXN: $7.26 vs. TNFA: $0.09)
Brand notoriety: SLXN and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 19% vs. TNFA: 493%
Market capitalization -- SLXN: $5.66M vs. TNFA: $873.74K
SLXN [@Biotechnology] is valued at $5.66M. TNFA’s [@Biotechnology] market capitalization is $873.74K. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • SLXN’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, both SLXN and TNFA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 5 TA indicator(s) are bullish while TNFA’s TA Score has 4 bullish TA indicator(s).

  • SLXN’s TA Score: 5 bullish, 3 bearish.
  • TNFA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than TNFA.

Price Growth

SLXN (@Biotechnology) experienced а +6.45% price change this week, while TNFA (@Biotechnology) price change was -5.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLXN($5.66M) has a higher market cap than TNFA($874K). SLXN YTD gains are higher at: -75.920 vs. TNFA (-92.174). TNFA has higher annual earnings (EBITDA): -8.35M vs. SLXN (-17.81M). TNFA has more cash in the bank: 5.88M vs. SLXN (3.47M). TNFA has less debt than SLXN: TNFA (2.68K) vs SLXN (3.7M). SLXN (0) and TNFA (0) have equivalent revenues.
SLXNTNFASLXN / TNFA
Capitalization5.66M874K647%
EBITDA-17.81M-8.35M213%
Gain YTD-75.920-92.17482%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.47M5.88M59%
Total Debt3.7M2.68K138,088%
FUNDAMENTALS RATINGS
TNFA: Fundamental Ratings
TNFA
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLXNTNFA
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
35%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
22%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
28%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
38%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOLO4.680.17
+3.77%
MicroCloud Hologram Inc
DYN13.640.26
+1.94%
Dyne Therapeutics
CHSCP28.890.09
+0.33%
CHS
CWBC21.32-0.01
-0.05%
Community West Bancshares
RVTY88.59-2.64
-2.89%
Revvity

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.83%
IMA - SLXN
63%
Loosely correlated
+0.07%
CELC - SLXN
50%
Loosely correlated
+1.01%
MRSN - SLXN
43%
Loosely correlated
-0.26%
CHRS - SLXN
26%
Poorly correlated
+0.88%
QSI - SLXN
25%
Poorly correlated
-0.85%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
+15.53%
ARTV - TNFA
47%
Loosely correlated
+15.14%
COGT - TNFA
39%
Loosely correlated
+1.14%
PHAT - TNFA
39%
Loosely correlated
-1.11%
TVGN - TNFA
36%
Loosely correlated
-0.12%
LRMR - TNFA
32%
Poorly correlated
+0.78%
More